Come up with a name for your new list and we'll add to it:
COARE Biotechnology raised a round of funding on January 01, 2010. Investors include
Qualifying Therapeutic Discovery Project.
COARE Biotechnology is focused on targeting tumor-initiating cells in solid tumor cancers. The company utilizes markers of tissue stem/progenitor cells as therapeutic targets. Utilizing tumor xenograf…